Dec.10 — Bloomberg’s Sarah Frier and Eric Haggstrom of Emarketer talk about the growth of ad spending on Instagram. They appear on “Bloomberg Technology.” …read more […]
Q3 2019 Spirit Realty Capital Inc Earnings Call …read more […]
On Tuesday, GameStop reported third-quarter results and outlook that fell short of Wall Street expectations. The company disclosed that it repurchased 22.6 Million shares for $115.7 million during the quarter, which it says underscores “commitment to returning capital to shareholders.” For the quarter, GameStop’s total global sales decreased 25.7% to $1.4 billion, driven by a consolidated comparable store sales decrease of 23.2%. …read more […]
SAN FRANCISCO/TOKYO (Reuters) – D-Wave Systems, a Canadian quantum computer firm backed by billionaire Jeff Bezos, Wall Street titan Goldman Sachs and others, said Japan’s NEC Corp will invest in it as part of a fundraising round and will also help it develop software. Dan Cohrs, chief financial officer at D-Wave, told Reuters on Tuesday NEC has committed to investing $10 million in the fundraising round which could close in January. Bezos Expeditions, Amazon CEO Jeff Bezos’ personal investment fund, In-Q-Tel, the Central Intelligence Agency’s venture capital firm, Fidelity Investments, and Goldman are among D-Wave’s investors. …read more […]
GameStop Corp reported a plunge in quarterly sales and slashed its full-year profit forecast on Tuesday, as the company struggles with consumers delaying purchases ahead of the launch of new consoles, sending its shares plunging 21%. Latest versions of Sony Corp’s PlayStation and Microsoft Corp’s Xbox are due to be unveiled next year, with video game and console retailers also hit by the shift to downloadable or streamable games and away from physical versions. GameStop now sees full-year earnings per share in the range of 10 cents to 20 cents, down from an earlier forecast of $1.15 to …read more […]
U.S. oil major Chevron Corp said on Tuesday it is evaluating strategic alternatives, including divestment of gas-related assets in Appalachia shale, Kitimat LNG, and other international projects. Chevron, which set a 2020 spending program of $20 billion, said these actions are estimated to result in non-cash, after tax impairment charges of $10 billion to $11 billion in its fourth quarter, with more than half related to the Appalachia shale. Chevron reported a 36% drop in third-quarter profit, hit by lower oil and gas prices and refining margins, and warned higher costs would affect its current-quarter results. …read more […]
Alan “Ace” Greenberg was a legend on Wall Street. Greenberg arrived at Bear Stearns in 1949 with no experience in financial markets.
Starting from the bottom rung of the trading floor, Greenberg rose through the ranks to become CEO in 1978, a position he held until 1993.
Greenberg was executive chairman when Bear was forced to sell itself to J.P. Morgan during the financial crisis, a sad ending to an otherwise glorious career.
Although he had no formal background in securities or trading, Greenberg thrived on the trading floor. A former college football player, he was physically and mentally tough. He was known …read more […]
House Democrats announced on Tuesday that it would support the passage of the United States-Mexico-Canada Agreement (USMCA) after the deal spent months in limbo. …read more […]
When you’re looking for so-called “value” in year No. 10 of a bull market, it’s not easy to find quality companies trading in Wall Street’s bargain bin.
However, there’s one company I’d like to bring to your attention today which I feel could offer you the best “buy low” opportunity within the entire technology sector.
In today’s Trade of the Day, I’ll tell you the name of the company, why I like it and exactly how members are playing it right now in The War Room.
So let’s get started…
The company that’s now a tech bargain is Cisco Systems (Nasdaq: CSCO).
As I’m sure …read more […]
Hedge funds are known to underperform the bull markets but that’s not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exorbitant fees. No one knows what the future holds and how market participants will react to the bountiful news that floods in each […] …read more […]
French biopharmaceutical company hopes to become first to get approval of treatment for liver disorder that affects up to 30 million Americans Continue reading… …read more […]
Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp’s drug to correct irregular rhythm in the upper chambers of the heart in adult patients, the latest setback to the company’s efforts to market a potential blockbuster in the country. The panel voted 11-2 against approving the drug, Brinavess, citing serious safety risks, including low blood pressure and irregular rhythm in the lower heart chambers, and deaths during the trials. “It clearly has benefit but it does have risk,” said panel member Dr. Barry Davis of the University of Texas School …read more […]
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […] …read more […]
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] …read more […]
The drug stock is ripe for a short squeeze, too …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
